Biotech · Private company
Polarean, Inc.
Track this companyFree. Adds Polarean, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- 129Xe MRIPhase 3 · Pulmonary Surgical ProceduresClinicalTrials.gov · fetched Nov 12, 2026
- 133 Xe scintigraphyPhase 3 · Pulmonary Surgical ProceduresClinicalTrials.gov · fetched Nov 12, 2026
- 133XE scintigraphyPhase 3 · Pulmonary Surgical ProceduresClinicalTrials.gov · fetched Nov 12, 2026
- Albuterol Sulfate, 2.5 Mg/3 mL (0.083%) Inhalation SolutionPhase 1 · Chronic Obstructive Pulmonary DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Jet NebulizerPhase 1 · Chronic Obstructive Pulmonary DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Metered Dose InhalerPhase 1 · Chronic Obstructive Pulmonary DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Vibrating Mesh NebulizerPhase 1 · Chronic Obstructive Pulmonary DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Downstream Effects of Airway Mucus Plugs on 129Xenon MRI in Severe AsthmaRECRUITING · started Nov 17, 2025ClinicalTrials.gov NCT07139899 · fetched Nov 12, 2026
- Comparison of Bronchodilator Response From Three Different Aerosol Delivery Methods in Patients With COPD Using Hyperpolarized Xe 129 MRI Ventilation ImagingPHASE1 · ACTIVE_NOT_RECRUITING · started Mar 19, 2024ClinicalTrials.gov NCT06271408 · fetched Nov 12, 2026
- Hyperpolarized Xenon MRI for Assessment of Pulmonary Function in Lung ResectionPHASE3 · COMPLETED · started Aug 17, 2018ClinicalTrials.gov NCT03417687 · fetched Nov 12, 2026
- Hyperpolarized Xenon MRI for Assessment of Pulmonary Function in Lung TransplantPHASE3 · COMPLETED · started Aug 17, 2018ClinicalTrials.gov NCT03418090 · fetched Nov 12, 2026